Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors

Bjorn Brandsaeter, Erik Schrumpf, Oystein Bentdal, Kurt Brabrand, Hans Jorgen Smith, Andreas Abildgaard, Ole Petter Clausen, Kristian Bjoro – 23 September 2005 – Primary sclerosing cholangitis (PSC) is a well‐established indication for orthotopic liver transplantation (OLT), but post‐OLT bile duct strictures complicate the outcome for these patients. These strictures might represent recurrent PSC (rPSC).

Endothelin activation and postoperative renal failure after human liver transplantation

Hubert Hetz, Michael Bauer, Daniel Lahner, Peter Faybik, Johannes Winning, Hendrik Jan Ankersmit, Andreas Bacher, Claus Georg Krenn – 23 September 2005 – Renal failure is an established risk factor for impaired patient outcome after orthotopic liver transplantation (OLT). As the endothelin pathway is known to be involved in the development of acute renal failure (ARF), we designed a study to clarify its role in ARF following OLT. Twenty consecutive patients with intact kidney function scheduled for their first OLT were prospectively studied.

Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV‐infected liver graft recipients

Peter Stärkel, Michel Stoffel, Jan Lerut, Yves Horsmans – 23 September 2005 – Strategies using lamivudine and hepatitis B immunoglobulins (HBIg) for prevention of hepatitis B virus (HBV) reinfection after liver transplantation (LT) are expensive since life‐long treatment is needed.

Subscribe to